Skip to main content

Type 1 Diabetes News

Type 1 Diabetes is a chronic condition in which your body loses the ability to produce insulin, which is necessary for most cells to convert food into energy and regulate blood sugar levels. 

Thoughts on democratizing health care, precision medicine, and more from Stanford MedX 2015.
Hello there from San Francisco! I wanted to weigh in, so to speak, on Adam Brown’s valuable column this month . His in-depth inquiry shows what a “low-carb” and “non-low...
Plus, my Resolutions for 2016!
"Non-compliance is a term that is banned in my unit…"
My somewhat-impatient response to the recent New York Times article, “Some Older Patients Are Treated Not Wisely, but Too Much.”
A blast from the past! I was delighted to learn recently that one of my very first bosses at Goldman Sachs – the wonderful and incredibly kind David M. Darst, Sr. –...
“There are still too many people who do not have access to a life-saving product that was discovered 95 years ago...”
Shipping now! Patients must decide between data on the phone or pump.
What does this controversial data mean for the type 2 diabetes epidemic?
Crowdfunding – say hello to diabetes with Diabetes Research Connection.
The two organizations expand their research partnership to support glucose responsive insulin.
How you can tell drug and device makers what YOU want from diabetes products.
What I learned from doubling my carb intake: more work, more danger, but the same average blood sugar. Huh?
Goal to maintain access to therapy over next six months. What challenges have been seen to date?
Why we’re fans of the newest Bluetooth-enabled meter with an FDA-approved bolus advisor app.
At the Children with Diabetes Friends for Life Conference this month, I had the incredible opportunity to speak to ~100 teenagers with diabetes. My talk, “10 Tips for...
Kerri Sparling of Six Until Me interviews members of the Diabetes Online Community on what makes "Spare a Rose" so meaningful.
Diagnoses stabilizing, though 83% of 65+ year olds have diabetes or prediabetes.
How a culture of stigma and shame is hurting the conversation about diabetes.
Bringing accountability and investor thinking to big health challenges. Plus, Q&A with Founder Esther Dyson.

Pages